Every illusion has a backstage crew. New research shows the brain’s own “puppet strings”—special neurons that quietly tug our perception—help us see edges and shapes that don’t actually exist. When…
Beate Mueller- Tiemann, PhDCTO, Cytiva In recent decades, sensor-less cars that rely on human decision-making have evolved into self-driving taxis that arrive on demand. Beate Mueller-Tiemann, PhD, CTO of the…
A novel strategy developed by scientists at Rice University allows scientists to zoom in on tiny segments of proteins inside living cells, revealing localized environmental changes that could indicate the…
A July report by a team of Jefferies analysts paints an upbeat picture for contract development and manufacturing organizations (CDMOs). Miyabi Yamakita and colleagues reported rising demand for the services…
Credit: Charles River Laboratories Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset,…
Tim Harris, PhDOperating PartnerSV Health Investors Perfect Preparation Prevents Poor Performance.” These five Ps—with maybe a sixth before the word “poor”—is a traditional saying about the need for careful planning…
Iterative development is a fixture in manufacturing environments where ideas are conceived, needs and aspirations are reassessed in light of those ideas, and then advanced to something that, often, is…
Introduction Microbial production systems, such as Escherichia coli and yeast, are becoming more important than ever in manufacturing innovative biologics—including nanobodies, enzymes, cytokines, growth hormones, virus-like particles, and other complex…
With governments and environmental organizations pushing industries to reduce their greenhouse gas emissions, biopharmaceutical companies around the world are finding ways to make their business more sustainable. They have signed…
The global capacity squeeze in the biomanufacturing sector is intensifying. While innovation in biologics continues apace, with an expanding portfolio of complex modalities, the available infrastructure has become increasingly limited,…